Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial

BACKGROUND: Elderly patients represent a major fraction of non-small cell lung cancer (NSCLC) patients in routine clinical practice, but they are still underrepresented in clinical trials. In particular, data regarding efficacy and safety in frail or elderly patients with respect to immunotherapy ar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Kuon, Jonas, Hommertgen, Adriane, Krisam, Johannes, Lasitschka, Felix, Stenzinger, Albrecht, Blasi, Miriam, Bozorgmehr, Farastuk, Maenz, Martin, Kieser, Meinhard, Schneider, Marc, Thomas, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7178741/
https://ncbi.nlm.nih.gov/pubmed/32321565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04280-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados